Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print New Cell Transplantation Technique Restores Insulin Production in Diabetics

New Cell Transplantation Technique Restores Insulin Production in Diabetics

November 30, 2005

Researchers are using a new cell transplantation technique to restore the cells that produce insulin in patients with type 1 diabetes. The method is minimally invasive, with few complications. The study was presented today at the annual meeting of the Radiological Society of North America (RSNA).

"We used ultrasound guidance to inject donor cells into the portal vein of diabetic patients, which is accessed through the skin," said co-author Saravanan Krishnamoorthy, M.D., radiology resident at the University of Minnesota in Minneapolis. "This is a safe method of cell transplantation that could potentially become a same-day procedure."




In type 1 diabetes, the body does not produce insulin. This typically results from the destruction of insulin-producing islet beta cells in the pancreas. Insulin is necessary to metabolize sugar, which is the basic fuel that all cells need.

With this minimally invasive technique, donor islet cells are injected into diabetic patients so that the new, healthy islet cells can restore insulin production, essentially stopping the progression of the disease. The study included 13 patients with poorly controlled type 1 diabetes. Fifteen islet cell transplants were completed-two patients underwent two procedures to achieve correct needle placement.

"We used a steroid-free protocol to suppress the immune system, so that the body accepted the transplanted cells," Dr. Krishnamoorthy said. "We also developed a 'sandwich technique' to close the access site through the skin, where the islet cells are injected. The sandwich technique is so-called because of the layered applications of gelfoam and coil used to close the access site."

Dr. Krishnamoorthy said that even though percutaneous islet cell transplantation is currently an experimental procedure, the sandwich closure is a safe method that prevents many of the complications common to previous techniques used to transplant islet cells. Thirty days after the procedure, all 13 patients were producing insulin without requiring supplemental injections, and none experienced major complications. Liver function tests and blood cell counts were monitored carefully during this time.

In the future, Dr. Krishnamoorthy looks toward the potential use of stem cells for this purpose, and also the development of better immunosuppressive medications to keep the body from rejecting the transplanted islet cells.

Type 1 diabetes, formerly known as juvenile diabetes, is a debilitating disease that is usually diagnosed in children and young adults. It can result in significant morbidity, causing vision loss, loss of sensation that results in severe infections, fractures and amputations, destruction of major organ function (e.g., the kidneys) and cardiovascular disease that can result in complications such as heart attacks. Both genetic and environmental factors contribute to the disease.

Radiological Society of North America



Related Insulin Production News Articles Insulin Production News and Current Insulin Production Events RSS Insulin Production News and Current Insulin Production Events RSS
Type 2 Diabetes May Be Caused by Intestinal Dysfunction
Growing evidence shows that surgery may effectively cure Type 2 diabetes - an approach that not only may change the way the disease is treated, but that introduces a new way of thinking about diabetes.

Protein power: Researchers trigger insulin production in diabetic mice
If the human body were a stage, then proteins would rank among the lead actors in the play we call "Life."

A low-carb diet may stunt prostate tumor growth
A diet low in carbohydrates may help stunt the growth of prostate tumors, according to a new study led by Duke Prostate Center researchers.

Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
Researchers at Children's Hospital of Pittsburgh of UPMC are participating in an international clinical trial currently underway to study the effectiveness of oral insulin in preventing or delaying the onset of type 1 diabetes in people at risk for the disease.

Obesity boosts gullet cancer risk 6-fold
Obese people are six times as likely to develop gullet (oesophageal) cancer as people of 'healthy' weight, shows research published ahead of print in the journal Gut.

Botched production of insulin molecule may lead to diabetes
Picture a pretzel factory production line, with conveyer belts carrying the dough, formed into unbaked pretzels, down to the oven to be cooked. Now imagine what would happen if pretzel dough started to overflow the mixer and oozed as a blob onto the conveyor, misshapen, and sticking fast to the dough of the other fully formed, unbaked pretzels.

Mutations in the insulin gene can cause neonatal diabetes
Mutations in the insulin gene can cause permanent neonatal diabetes, an unusual form of diabetes that affects very young children and results in lifelong dependence on insulin injections.

Cord blood may preserve insulin levels in children with type 1 diabetes
Umbilical cord blood may safely preserve insulin production in children newly diagnosed with type 1 diabetes, according to findings from a small national pilot study presented Monday (June 25) at the American Diabetes Association's 67th Scientific Sessions in Chicago.

Study tests oral insulin to prevent type 1 diabetes
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.

The stem cells that weren't there
Diabetes researchers, investigating how the body supplies itself with insulin, discovered to their surprise that adult stem cells, which they expected to play a crucial role in the process, were nowhere to be found.
More Insulin Production News Articles
The effect of adlay oil on plasma lipids, insulin and leptin in rat. : An article from: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
by B.-W. Huang, M.-T. Chiang, H.-T. Yao, W. Chiang

This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Thomson Gale on June 1, 2005. The length of the article is 5408 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it...

Effects of fraction SX of maitake mushroom on insulin resistance.: An article from: Original Internist
by Harry G. Preuss, Nadeem Talpur, Bobby Echard, Azad Dadgar, Sarla Aggarwal, Cun Zhuang, Manashi Bagchi, Debasis Bagchi

This digital document is an article from Original Internist, published by Original Internist, Inc. on June 1, 2003. The length of the article is 3647 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Insulin, its production, purification and physiological action
by D. W Hill



Estradiol-17@b and dihydrotestosterone differentially regulate vitellogenin and insulin-like growth factor-I production in primary hepatocytes of the tilapia ... Biochemistry and Physiology, Part C]
by L.G. Riley, T. Hirano, E.G. Grau

This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Effects of estradiol-17@b (E"2) and 5@a-dihydrotestosterone (DHT) on the production of vitellogenin...

© 2008 BrightSurf.com